C4 THERAPEUTICS INC. - COMMON STOCK
5.3800
04-October-24 15:59:56
15 minutes delayed
Stocks
+0.0400
+0.75%
Today's range
5.1800 - 5.4800
ISIN
N/A
Source
NASDAQ
-
C4 Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
03 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022
26 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
04 Aug 2022 08:00:03 By Nasdaq GlobeNewswire
-
02 Aug 2022 08:00:03 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
05 May 2022 08:00:02 By Nasdaq GlobeNewswire
-
08 Apr 2022 13:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Utpal Koppikar to Board of Directors
16 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
09 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
08 Mar 2022 16:30:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Full Year 2021 Financial Results and Recent Business Highlights
24 Feb 2022 07:00:03 By Nasdaq GlobeNewswire
-
C4 Therapeutics Announces 2022 Key Milestones to Advance Targeted Protein Degradation Portfolio
10 Jan 2022 07:00:02 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
03 Jan 2022 07:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Added to NASDAQ Biotechnology Index
17 Dec 2021 08:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Recent Business Highlights and Third Quarter 2021 Financial Results
10 Nov 2021 16:01:01 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
11 Aug 2021 16:02:00 By Nasdaq GlobeNewswire
-
11 Aug 2021 16:01:00 By Nasdaq GlobeNewswire
-
21 Jun 2021 16:01:00 By Nasdaq GlobeNewswire